Stewardship Financial Corporation Declares Cash Dividend
Jan 19, 2017 21:05 pm UTC| Business
MIDLAND PARK, N.J., Jan. 19, 2017 -- The Board of Directors of Stewardship Financial Corporation (NASDAQ:SSFN), parent company of Atlantic Stewardship Bank, has declared a $0.03 per share cash dividend. Common...
Jan 19, 2017 21:05 pm UTC| Business
DURHAM, N.C., Jan. 19, 2017 -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis®...
Franklin Universal Trust Declares Monthly Dividend
Jan 19, 2017 21:05 pm UTC| Business
SAN MATEO, Calif., Jan. 19, 2017 -- Franklin Universal Trust (NYSE:FT), a closed-end investment company managed by Franklin Advisers, Inc., announced today a dividend of $0.032 per share, payable February 15, 2017, to...
Franklin Limited Duration Income Trust Declares Monthly Dividend
Jan 19, 2017 21:05 pm UTC| Business
SAN MATEO, Calif., Jan. 19, 2017 -- Franklin Limited Duration Income Trust (NYSE MKT:FTF), a closed-end investment company managed by Franklin Advisers, Inc., announced today a dividend of $0.1086 per common share,...
Micron Technology to Host Analyst Conference
Jan 19, 2017 21:05 pm UTC| Business
BOISE, Idaho, Jan. 19, 2017 -- Micron Technology, Inc. (NASDAQ:MU) will host an analyst conference on Thursday, February 2, 2017. Presentations by Micron executives will begin at 9 a.m. MT and the event is expected to...
Affimed Announces Proposed Public Offering of Common Stock
Jan 19, 2017 21:04 pm UTC| Business
Heidelberg, Germany January 19, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that it has...
Stemline Therapeutics Announces Proposed Public Offering of Common Stock
Jan 19, 2017 21:04 pm UTC| Business
NEW YORK, Jan. 19, 2017 -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced that it intends to offer and sell, subject to...